Rubius Therapeutics To Go Ex-Dividend On January 2nd, 2024 With 0.05794 USD Dividend Per Share

December 27th - $Rubius Therapeutics(RUBY.US)$ is trading ex-dividend on January 2nd, 2024. Shareholders of record on December 26th, 2023 will receive 0.05794 USD dividend per share on December 29

moomoo NewsDec 26, 2023 19:55 ET

Rubius Therapeutics (NASDAQ:RUBY) and Vigil Neuroscience (NASDAQ:VIGL) Critical Survey

Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two busin

Financial News LiveApr 20, 2023 04:25 ET

Head to Head Analysis: Rubius Therapeutics (NASDAQ:RUBY) Versus Vigil Neuroscience (NASDAQ:VIGL)

Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two busines

Defense WorldApr 16, 2023 01:32 ET

National Bank Presents List of ETFs to Help Investors Monitor Market Situation

12:09 PM EDT, 03/15/2023 (MT Newswires) -- National Bank on Tuesday presented a list of exchange-traded funds that investors can use to monitor the rapidly evolving situation amid the collapse of the

MT NewswiresMar 15, 2023 12:12 ET

Rubius Therapeutics, Inc. (NASDAQ:RUBY) Sees Large Increase in Short Interest

Rubius Therapeutics, Inc. (NASDAQ:RUBY – Get Rating) was the recipient of a significant increase in short interest in February. As of February 28th, there was short interest totalling 2,800,000 shares

kopsourceMar 11, 2023 15:04 ET

Cardiol Therapeutics (NASDAQ:CRDL) & Rubius Therapeutics (NASDAQ:RUBY) Critical Survey

Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companie

Defense WorldMar 9, 2023 01:05 ET